that found ethnicity to be the only significant factor that predicted human papillomavirus (HPV) vaccine uptake amongst adolescent girls in England, UK.
Shortly after the start of the vaccination programme, multivariate analysis of our cross-sectional study demonstrated that the level of knowledge regarding the HPV vaccination programme was significantly lower amongst children of non-white ethnicity. 2 It is worth considering therefore that lower level of knowledge could lead to lower uptake.
Bowyer et al. also suggest researching additional factors that may predict HPV vaccine uptake. Having further analysed our data, we would like to report new relevant findings.
Our study involved distributing a questionnaire to students and respective parents from a girls' private school, a girls' comprehensive (state) school and a mixed-sex comprehensive school in Birmingham, UK. The questionnaire consisted of eight knowledge-based questions regarding HPV and its vaccination programme. These questions were based on a National Health Service leaflet provided to all children at vaccination. 3 In total, 568 questionnaires were distributed, with 434 responses (76.4%).
Interestingly we have found no significant difference in the level of knowledge between students from the girls' private school and the girls' comprehensive school. However, even when taking into account the general poor performance of males and ethnic minority participants in the study, 2 students from the mixed comprehensive school obtained lower scores in the test. Students from the girls' comprehensive school obtained on average 1.5 (out of 8) marks higher than students from the mixed comprehensive school ( p<0.001). Girls from the private school obtained on average 2 (out of 8) marks higher than students from the mixed comprehensive school ( p<0.001) ( Table 1) .
Furthermore, in the questionnaire we asked the students' parents/guardians how many other sons/daughters they had. We then compared the scores obtained from different families. The results showed that families with more daughters obtained higher marks in the test. Conversely, families with more sons obtained poorer scores.
In summary, our results demonstrate that schools and even families with more male children are more likely to have poor knowledge about HPV and its vaccination programme. This may lead to lower intention to promote uptake in such schools and families. Countries including the USA and Australia have already started offering the HPV vaccine to males. There is still ongoing debate about introducing the male HPV vaccine in the UK. Our results therefore could have significant implications for information provision and the targeting of future education programmes. 
